Skip Navigation

Stamford Hospital joins Dana-Farber/Brigham and Women's Cancer Care Collaborative

  • Collaborative membership reflects commitment to excellence in patient care, clinical operations and scientific research in oncology

    Edward J. Benz, Jr., MD

    The Stamford Hospital Carl & Dorothy Bennett Cancer Center is the newest member of the Dana-Farber/Brigham and Women’s Cancer Care Collaborative (DF/BWCCC), and the first in Connecticut, Dana-Farber Cancer Institute and Brigham and Women’s Hospital announced today. Participation in the collaborative reflects the Bennett Cancer Center’s demonstrated commitment to excellence by meeting a wide array of standards and best practices.

    As part of the membership process, Dana-Farber/Brigham and Women’s Cancer Center clinicians and other staff conducted an extensive review of Stamford’s outpatient medical oncology and radiation oncology practices and procedures, including patient safety protocols, nursing and pharmacy practices, chemotherapy administration, and information systems.

    “We are proud to be the newest member joining the well-regarded and nationally recognized institutions behind the Dana-Farber/Brigham and Women’s Cancer Care Collaborative,” said Brian G. Grissler, President and CEO, Stamford Health. “As we prepare to open our new hospital in September, this relationship will expand our cancer expertise and solidify our vision to provide the best cancer care for our community today, while ensuring access to the latest in treatments and research for the future.”

    Stamford Hospital’s Bennett Cancer Center’s membership in the collaborative enhances staff access to educational opportunities and the ability to consult with medical specialists at Dana-Farber/Brigham and Women’s Cancer Center in Boston regarding complex cases. In addition, patients will have greater access to the latest cancer research and clinical trials. The practices and procedures of DF/BWCCC members are reviewed annually and new innovations and standards in patient cancer care will be shared and rapidly implemented at member hospitals.

    “Dana-Farber exists to help relieve the burden of cancer for as many people as possible,” said Edward J. Benz, Jr., MD, president of Dana-Farber Cancer Institute. “We fulfill this mission by conducting research to help create better preventative and diagnostic capabilities and therapies, by caring for our patients, and most recently, by working with other institutions, such as the Bennett Cancer Center at Stamford Hospital, to help them provide great care close to home,” he said. “We are excited about working more closely with such a strong and high quality partner as Stamford Hospital.”

    “Brigham and Women’s Hospital is dedicated to transforming the future of health care,” said Betsy Nabel, MD, president of Brigham and Women’s Health Care. “Through our partnership with Dana-Farber, we are on the leading edge of cancer care, and we are delighted to extend our knowledge and resources to community providers like Stamford Hospital for the benefit of patients and families in the Fairfield County region.”

Posted on July 13, 2016

  • Edward J. Benz Jr., MD
  • Media Contacts

    For all inquiries, call 617-632-4090 and ask to speak to a member of the media team. Please direct emails to media@dfci.harvard.edu.

  • New Patient Appointments

    For adults: 877-442-3324
    For children: 888-733-4662

    Make Appointment Online